Market Capitalization of Alembic Pharmaceuticals (APLLTD)
As of June 25, 2026, Alembic Pharmaceuticals (APLLTD) market capitalisation is ₹15346.67 Cr ($1.71B), with 19.89 Cr shares outstanding at a current price of ₹771.50 on NSE, ranking 446 out of 5363 companies by market cap in our screener. Alembic Pharmaceuticals operates in the Healthcare sector and is classified as a Mid Cap stock. Analyse APLLTD shareholding pattern to track promoter, FII and institutional holdings.
Market Cap History of Alembic Pharmaceuticals (Last 10 Years)
APLLTD market capitalisation from year-end NSE closing prices over the last 10 years. Read Alembic Pharmaceuticals dividend payments for the complete payout history and dividend yield track record.
End of Year Market Cap History — Alembic Pharmaceuticals
APLLTD year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. For live price, earnings and the complete company profile, see APLLTD share price screener.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹15346.67 Cr
$1.71B USD
|
₹771.50 | NSE | -8.82% |
| 2025 |
₹16831.61 Cr
$1.87B USD
|
₹846.15 | NSE | -20.64% |
| 2024 |
₹21209.83 Cr
$2.36B USD
|
₹1066.25 | NSE | +40.41% |
| 2023 |
₹15105.98 Cr
$1.68B USD
|
₹759.40 | NSE | +32.55% |
| 2022 |
₹11396.12 Cr
$1.27B USD
|
₹572.90 | NSE | -28.56% |
| 2021 |
₹15951.39 Cr
$1.77B USD
|
₹801.90 | NSE | -22.43% |
| 2020 |
₹20563.34 Cr
$2.28B USD
|
₹1033.75 | NSE | +80.95% |
| 2019 |
₹11364.29 Cr
$1.26B USD
|
₹571.30 | NSE | -4.74% |
| 2018 |
₹11929.23 Cr
$1.33B USD
|
₹599.70 | NSE | +13.02% |
| 2017 |
₹10554.69 Cr
$1.17B USD
|
₹530.60 | NSE | -10.84% |
| 2016 |
₹11837.72 Cr
$1.32B USD
|
₹595.10 | NSE | -14.50% |
| 2015 |
₹13845.82 Cr
$1.54B USD
|
₹696.05 | NSE | +56.36% |
| 2014 |
₹8854.92 Cr
$983.88M USD
|
₹445.15 | NSE | +110.87% |
| 2013 |
₹4199.20 Cr
$466.58M USD
|
₹211.10 | NSE | +191.17% |
| 2012 |
₹1442.17 Cr
$160.24M USD
|
₹72.50 | NSE | +104.51% |
| 2011 |
₹705.17 Cr
$78.35M USD
|
₹35.45 | NSE | - |